Pentracor wins "Zukunftspreis Brandenburg" 2021

November 16, 2021
The medical technology company Pentracor GmbH from Hennigsdorf wins the Zukunftspreis Brandenburg 2021, the most important business award in the state of Brandenburg. From 82 applicants and 12 finalists, the jury selected six prize winners and one company as a special prize winner. The award ceremony took place on November 12 at the Airport Center Berlin Schönefeld. "We are very honored by this award," said Dr. Ahmed Sheriff, Managing Director of Pentracor GmbH.

Therapeutic Success with novel blood washing therapy - Interview with Dr. Ahmed Sheriff

Hennigsdorf, August 2021 - The medical technology company Pentracor GmbH, based in Hennigsdorf near Berlin, publishes an interview with CEO Dr. Ahmed Sheriff.

The innovative and cutting-edge therapy CRP apheresis convinces.

Avoiding serious tissue damage in myocardial infarction and preserving cardiac output. A clinical study on CRP apheresis after myocardial infarction showed significantly positive results. Other cases in clinical practice support these results. Similarly, 9 Covid-19 patients - one before and the others in intensive care - have recovered. The majority were already on artificial ventilation. Unfortunately, about 50 percent of these patients die under normal conditions when treated according to guidelines.